Identity
- Security key
- 20182
- Ticker
- PLRZ
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2024-10-29
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- PLRZ
Detail
Enriched 2026-08-14 20:47
- Market cap
- $20,256,275.88
- Shares outstanding (class)
- 2,083,979
- Shares outstanding (weighted)
- 2,083,979
- SIC
- —
- Employees
- 1
- Location
- —
- Description
Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. The company's technology platforms are Capture & Contain and Trap & Target.
Market cap and share counts drift.